Representation matters: inclusivity in clinical trials

Because disease outcomes and responses to treatment can vary across populations, clinical research must include patients who are racially, ethnically and gender representative of those who experience health conditions.

Scientists are pioneering new ways of achieving inclusive and diverse clinical trials, which can lead to a better understanding of disease biology and ultimately improved treatment and care for women and other populations that have historically been excluded from research in the past.

Tune in to hear Maria Wilson, Executive Director, Project Team Leader, Genentech sits down with Nicole Richie, Global Head of Health Equity and Population Science, and Jenn Pangilinan, Vice President, Genentech Research and Early Development (gRED) Clinical Operations, discuss the nuances of human biological difference and how we can take a more thoughtful approach to diversity in clinical trials.

Listen to the episode here

More stories of X

See all stories

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeCovid-19Pharma solutionsRoche careersMedia libraryAnnual Report 2023Privacy policyLegal statementAccessibility statement